Chenglin Mu

机构：Zhejiang Lab · ORCID：0009-0008-9695-8120

发表论文 18 篇 · 总被引 484 次 · h-index 12

代表论文

• Potential compound from herbal food of Rhizoma Polygonati for treatment of COVID-19 analyzed by network pharmacology: Viral and cancer signaling mechanisms (2020 · Journal of Functional Foods · 被引 130)
• Generation of particle assemblies mimicking enzymatic activity by processing of herbal food: the case of rhizoma polygonati and other natural ingredients in traditional Chinese medicine (2021 · Nanoscale Advances · 被引 63)
• Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19 (2021 · International Journal of Biological Sciences · 被引 45)
• The Love-Hate Relationship Between TGF-β Signaling and the Immune System During Development and Tumorigenesis (2022 · Frontiers in Immunology · 被引 39)
• Omicron N501Y mutation among SARS-CoV-2 lineages: In silico analysis of potent binding to tyrosine kinase and hypothetical repurposed medicine (2021 · Travel Medicine and Infectious Disease · 被引 36)
• Rhizoma polygonati from Mount Tai: nutritional value and usefulness as a traditional Chinese medicine, source of herbzyme, and potential remediating agent for COVID-19 and chronic and hidden hunger (2021 · Acupuncture and Herbal Medicine · 被引 35)